je.st
news
Sanofi, Regeneron drug fares well in study
2013-11-22 15:46:15| Biotech - Topix.net
A potential rheumatoid arthritis treatment from French drugmaker Sanofi and its U.S. development partner Regeneron Pharmaceuticals Inc. fared better than a fake drug at improving disease signs and symptoms in a late-stage study.
Tags: study
drug
fares
sanofi
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||